MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/24/2026

1. INTC
2. DECK
3. META
4. AMD
5. INFY
6. RNG
7. SPY
8. TMUS
9. UNP
10. GOOGL

Go back to MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
MACROGENICS (NASDAQ: MGNX) Delayed: 3.70 -0.31 (7.73%)
Previous Close $4.01    52 Week High $36.11 
Open $4.01    52 Week Low $14.84 
Day High $4.05    P/E 9.49 
Day Low $3.36    EPS $0.39 
Volume 2,653,531